常用參考文獻

1st

藥物相互作用研究技術(shù)指導原則（試行）（2021年1月） 

查看

2nd

U.S. Department of Health and Human Services Food and Drug Administration

Center for Drug Evaluation and Research (CDER)

In Vitro Drug Interaction Studies —Cytochrome P450 Enzyme- and  Transporter-Mediated Drug Interactions Guidance for Industry(January  2020 Clinical Pharmacology)

查看

3rd

Shujun Fu , Feifei Yu , Zhuohan Hu Tao Sun

Metabolism-mediated drug–drug interactions – Study design, data analysis, and implications for in vitro evaluations

查看

4th

 Shujun Fu , Feifei Yu , Tao Sun , Zhuohan Hu

Transporter-mediated drug–drug interactions – Study design, data analysis,and implications for in vitro evaluations

查看

5th

Watanabe,T., Kusuhara,H., Maeda,K., Kanamaru,H., Saito,Y., Hu,Z. and Sugiyama,Y.

Investigation  of the rate-determining process in the hepatic elimination of HMG-CoA  reductase inhibitors in rats and humans. Drug Metab. Dispos. 2010, 38,  215-222

查看

6th

Bent H. Hellum, Zhuohan Hu, Odd Georg Nilsen

The  Induction of CYP1A2, CYP2D6 and CYP3A4 by Six Trade Herbal Products in  Cultured Primary Human Hepatocytes. Basic & Clinical Pharmacology  & Toxicology. 2007, 100: 23-30

查看

7th

Takao  Watanabe, Hiroyuki Kusuhara, Tomoko Watanabe, Yasuyuki Debori, Kazuya  Maeda, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Brian W.  Ogilvie, Andrew Parkinson, Zhuohan Hu and Yuichi Sugiyama

Prediction  of the overall renal tubular secretion and hepatic clearance of anionic  drugs and a renal drug-drug interaction involving OAT3 in humans by in  vitro uptake experiments. Drug Metab. Dispos.2011,39: 1031-1038.

查看

8th

Wakaba Yamashiro, Kazuya Maeda, Masakazu Hirouchi, Yasuhisa Adachi, Zhuohan Hu,and Yuichi Sugiyama

Involvement  of transporters in the hepatic uptake and biliary excretion of  valsartan, a selective antagonist II AT-receptor, in humans.  Drug  Metab. Dispos. 2006, 37, 1247 - 1254

查看